RBM15 is a novel prognostic biomarker and correlates with immune cell infiltration in lung adenocarcinoma
Preprint in Research Square (April 2024)
The most recent citing publications are shown below. View all 59 publications that cite this research output on Dimensions.
Preprint in Research Square (April 2024)
Article in Frontiers in Physiology (April 2024)
Article in Frontiers in Oncology (March 2024)